vs
Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and AVANOS MEDICAL, INC. (AVNS). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $110.6M, roughly 1.6× American Assets Trust, Inc.). American Assets Trust, Inc. runs the higher net margin — 6.1% vs -0.7%, a 6.8% gap on every dollar of revenue. On growth, American Assets Trust, Inc. posted the faster year-over-year revenue change (1.8% vs 0.7%). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -0.1%).
Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
AAT vs AVNS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $110.6M | $180.9M |
| Net Profit | $6.7M | $-1.3M |
| Gross Margin | — | 47.5% |
| Operating Margin | 23.4% | 1.4% |
| Net Margin | 6.1% | -0.7% |
| Revenue YoY | 1.8% | 0.7% |
| Net Profit YoY | -16.3% | 99.7% |
| EPS (diluted) | $0.08 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.6M | — | ||
| Q4 25 | $110.1M | $180.9M | ||
| Q3 25 | $109.6M | $177.8M | ||
| Q2 25 | $107.9M | $175.0M | ||
| Q1 25 | $108.6M | $167.5M | ||
| Q4 24 | $113.5M | $179.6M | ||
| Q3 24 | $122.8M | $170.4M | ||
| Q2 24 | $110.9M | $171.7M |
| Q1 26 | $6.7M | — | ||
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $4.5M | $-1.4M | ||
| Q2 25 | $5.5M | $-76.8M | ||
| Q1 25 | $42.5M | $6.6M | ||
| Q4 24 | — | $-397.3M | ||
| Q3 24 | $16.7M | $4.3M | ||
| Q2 24 | $11.9M | $1.8M |
| Q1 26 | — | — | ||
| Q4 25 | 59.4% | 47.5% | ||
| Q3 25 | 60.5% | 48.4% | ||
| Q2 25 | 62.6% | 52.6% | ||
| Q1 25 | 62.0% | 53.6% | ||
| Q4 24 | 61.3% | 54.6% | ||
| Q3 24 | 65.5% | 54.5% | ||
| Q2 24 | 63.6% | 55.7% |
| Q1 26 | 23.4% | — | ||
| Q4 25 | 21.1% | 1.4% | ||
| Q3 25 | 22.6% | 0.1% | ||
| Q2 25 | 24.1% | -42.6% | ||
| Q1 25 | 66.3% | 6.1% | ||
| Q4 24 | 26.5% | -233.0% | ||
| Q3 24 | 30.8% | 7.0% | ||
| Q2 24 | 27.8% | 3.7% |
| Q1 26 | 6.1% | — | ||
| Q4 25 | — | -0.7% | ||
| Q3 25 | 4.1% | -0.8% | ||
| Q2 25 | 5.1% | -43.9% | ||
| Q1 25 | 39.2% | 3.9% | ||
| Q4 24 | — | -221.2% | ||
| Q3 24 | 13.6% | 2.5% | ||
| Q2 24 | 10.7% | 1.0% |
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | $-0.02 | ||
| Q3 25 | $0.07 | $-0.03 | ||
| Q2 25 | $0.09 | $-1.66 | ||
| Q1 25 | $0.70 | $0.14 | ||
| Q4 24 | $0.14 | $-8.64 | ||
| Q3 24 | $0.28 | $0.09 | ||
| Q2 24 | $0.20 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $118.3M | $89.8M |
| Total DebtLower is stronger | — | $90.3M |
| Stockholders' EquityBook value | $1.1B | $778.2M |
| Total Assets | $2.9B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $118.3M | — | ||
| Q4 25 | $129.4M | $89.8M | ||
| Q3 25 | $138.7M | $70.5M | ||
| Q2 25 | $143.7M | $90.3M | ||
| Q1 25 | $143.9M | $97.0M | ||
| Q4 24 | $425.7M | $107.7M | ||
| Q3 24 | $533.0M | $89.0M | ||
| Q2 24 | $114.9M | $92.2M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $90.3M | ||
| Q3 25 | — | $93.4M | ||
| Q2 25 | — | $95.7M | ||
| Q1 25 | — | $98.0M | ||
| Q4 24 | $2.0B | $125.3M | ||
| Q3 24 | — | $152.6M | ||
| Q2 24 | — | $164.9M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | $778.2M | ||
| Q3 25 | $1.2B | $778.0M | ||
| Q2 25 | $1.2B | $776.3M | ||
| Q1 25 | $1.2B | $839.4M | ||
| Q4 24 | $1.2B | $828.5M | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.2B | $1.2B |
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $1.1B | ||
| Q3 25 | $2.9B | $1.1B | ||
| Q2 25 | $3.0B | $1.0B | ||
| Q1 25 | $3.0B | $1.1B | ||
| Q4 24 | $3.3B | $1.2B | ||
| Q3 24 | $3.4B | $1.7B | ||
| Q2 24 | $3.0B | $1.7B |
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | 0.12× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | 1.72× | 0.15× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.13× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $28.2M |
| Free Cash FlowOCF − Capex | — | $21.3M |
| FCF MarginFCF / Revenue | — | 11.8% |
| Capex IntensityCapex / Revenue | 14.5% | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $167.1M | $28.2M | ||
| Q3 25 | $40.5M | $14.0M | ||
| Q2 25 | $49.2M | $6.8M | ||
| Q1 25 | $36.9M | $25.7M | ||
| Q4 24 | $207.1M | $57.9M | ||
| Q3 24 | $52.4M | $23.0M | ||
| Q2 24 | $59.3M | $27.8M |
| Q1 26 | — | — | ||
| Q4 25 | $94.9M | $21.3M | ||
| Q3 25 | $23.1M | $7.0M | ||
| Q2 25 | $28.4M | $-4.2M | ||
| Q1 25 | $20.4M | $19.0M | ||
| Q4 24 | $136.9M | $53.1M | ||
| Q3 24 | $28.0M | $20.0M | ||
| Q2 24 | $43.6M | $21.9M |
| Q1 26 | — | — | ||
| Q4 25 | 86.2% | 11.8% | ||
| Q3 25 | 21.1% | 3.9% | ||
| Q2 25 | 26.3% | -2.4% | ||
| Q1 25 | 18.8% | 11.3% | ||
| Q4 24 | 120.7% | 29.6% | ||
| Q3 24 | 22.8% | 11.7% | ||
| Q2 24 | 39.3% | 12.8% |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 65.6% | 3.8% | ||
| Q3 25 | 15.9% | 3.9% | ||
| Q2 25 | 19.3% | 6.3% | ||
| Q1 25 | 15.1% | 4.0% | ||
| Q4 24 | 61.9% | 2.7% | ||
| Q3 24 | 19.9% | 1.8% | ||
| Q2 24 | 14.1% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 8.98× | — | ||
| Q2 25 | 9.01× | — | ||
| Q1 25 | 0.87× | 3.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.15× | 5.35× | ||
| Q2 24 | 4.98× | 15.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
